image
Molecular Partners AG MOLN
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 3.54
-3.8 %
$ 131 M
Market Cap
-1.96
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
106.84%
EBIT Estimate
--0.07%
Net Income Estimate
--9.24%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Molecular Partners AG
image
MOLN has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart MOLN

image
$200.0m$200.0m$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MOLN

image
$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MOLN

image
$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029